The global hepatitis testing/diagnostic market size is expected to reach USD 4.36 Billion at a steady revenue CAGR of 4.7% in 2030, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by factors such as growing burden of hepatitis, introduction of molecular diagnostics for diagnosis of hepatitis, increasing awareness regarding this disease, and rising awareness regarding commercially available advanced products. Hepatitis is an inflammation of liver, commonly caused by hepatitis virus. Hepatitis testing is conducted to determine genotype of hepatitis triggering the ailment and also helps in determining best suited treatment for patient. Point-Of-Care (POC) testing helps to complete screening procedure without the need for a second visit and, in some cases, without leaving one’s house, which when combined with quick findings, lowers risk of problems and transmission. https://www.emergenresearch.co....m/industry-report/he